These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21605619)

  • 1. The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers.
    Dupouy S; Mourra N; Doan VK; Gompel A; Alifano M; Forgez P
    Biochimie; 2011 Sep; 93(9):1369-78. PubMed ID: 21605619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
    Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
    Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin expression and outcome of malignant pleural mesothelioma.
    Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
    Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic role of neurotensin and neurotensin receptors in various cancers.
    Ouyang Q; Zhou J; Yang W; Cui H; Xu M; Yi L
    Clin Exp Pharmacol Physiol; 2017 Aug; 44(8):841-846. PubMed ID: 28556374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.
    Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR
    Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin receptor 1 determines the outcome of non-small cell lung cancer.
    Alifano M; Souazé F; Dupouy S; Camilleri-Broët S; Younes M; Ahmed-Zaïd SM; Takahashi T; Cancellieri A; Damiani S; Boaron M; Broët P; Miller LD; Gespach C; Regnard JF; Forgez P
    Clin Cancer Res; 2010 Sep; 16(17):4401-10. PubMed ID: 20810387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Function and mechanism of neurotensin (NTS) and its receptor 1 (NTSR1) in occurrence and development of tumors.
    Hu HR; Dong Z; Yi L; He XY; Zhang YL; Liu YL; Cui HJ
    Zhongguo Zhong Yao Za Zhi; 2015 Jul; 40(13):2524-36. PubMed ID: 26697673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma.
    Gui X; Guzman G; Dobner PR; Kadkol SS
    Peptides; 2008 Sep; 29(9):1609-15. PubMed ID: 18541341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
    Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
    Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice.
    Kim ER; Leckstrom A; Mizuno TM
    Behav Brain Res; 2008 Dec; 194(1):66-71. PubMed ID: 18639588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phylogenetic history, pharmacological features, and signal transduction of neurotensin receptors in vertebrates.
    Hwang JI; Kim DK; Kwon HB; Vaudry H; Seong JY
    Ann N Y Acad Sci; 2009 Apr; 1163():169-78. PubMed ID: 19456337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoliposomal short-chain ceramide inhibits agonist-dependent translocation of neurotensin receptor 1 to structured membrane microdomains in breast cancer cells.
    Heakal Y; Kester M
    Mol Cancer Res; 2009 May; 7(5):724-34. PubMed ID: 19435815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression.
    Souazé F; Dupouy S; Viardot-Foucault V; Bruyneel E; Attoub S; Gespach C; Gompel A; Forgez P
    Cancer Res; 2006 Jun; 66(12):6243-9. PubMed ID: 16778199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
    Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
    Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin pathway in digestive cancers and clinical applications: an overview.
    Christou N; Blondy S; David V; Verdier M; Lalloué F; Jauberteau MO; Mathonnet M; Perraud A
    Cell Death Dis; 2020 Dec; 11(12):1027. PubMed ID: 33268796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.
    Wu Z; Fournel L; Stadler N; Liu J; Boullier A; Hoyeau N; Fléjou JF; Duchatelle V; Djebrani-Oussedik N; Agopiantz M; Ségal-Bendirdjian E; Gompel A; Alifano M; Melander O; Trédaniel J; Forgez P
    Cancer Lett; 2019 Mar; 444():147-161. PubMed ID: 30583074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.